SPAC27D7.11c Antibody

What is SPAC27D7.11c and why is it significant in yeast research?

SPAC27D7.11c is a gene in Schizosaccharomyces pombe (fission yeast, strain 972/ATCC 24843) with the UniProt accession number O42665 and Entrez Gene ID 2541615 . This protein is significant in yeast research as it enables the study of fundamental cellular processes in this model organism. To effectively study this protein, researchers typically employ immunological techniques using polyclonal antibodies that recognize the native or recombinant forms of the protein. Methodologically, researchers should first validate the expression pattern of SPAC27D7.11c in various growth conditions using RT-PCR before proceeding with antibody-based detection methods.

What applications are most suitable for the SPAC27D7.11c antibody?

The SPAC27D7.11c antibody has been validated primarily for ELISA and Western Blot applications . When designing experiments:

• For Western Blot: Use standard SDS-PAGE with 10-12% gels, transfer to PVDF membranes, and block with 5% non-fat milk. The expected molecular weight should be confirmed against the theoretical weight of the protein.

• For ELISA: Coat plates with 1-5 μg/ml of recombinant SPAC27D7.11c antigen and use the antibody at dilutions ranging from 1:1000 to 1:5000 to establish optimal signal-to-noise ratios.

The antibody has not been explicitly validated for immunohistochemistry, immunofluorescence, or immunoprecipitation applications, so preliminary optimization would be required for these approaches.

How should researchers optimize antibody dilutions for Western blot analysis?

For optimal Western blot results with the SPAC27D7.11c antibody, researchers should perform a dilution series experiment. Based on general principles from antibody research:

• Begin with a broad range (1:500 to 1:5000) of primary antibody dilutions

• Use consistent protein loading (20-50 μg of total protein)

• Document signal-to-noise ratio at each dilution

• Quantify band intensity versus background using densitometry software

This titration approach mirrors methodologies used in establishing monoclonal antibodies for research applications, where optimization is critical for reliable signal detection . The pre-immune serum provided with the antibody should be used as a negative control at equivalent dilutions to confirm specificity .

What is the recommended storage and handling protocol for maintaining SPAC27D7.11c antibody activity?

The SPAC27D7.11c antibody should be stored at -20°C or -80°C for long-term preservation of activity . Research on antibody stability suggests implementing the following protocol:

• Aliquot the antibody upon first thawing to minimize freeze-thaw cycles

• Use sterile techniques when handling to prevent contamination

• Add preservatives like sodium azide (0.02%) for aliquots stored at 4°C

• Monitor antibody performance periodically using positive controls

• Document any reduction in signal strength that may indicate degradation

Similar to approaches used in hybridoma-derived antibody preservation described in other research, proper storage significantly impacts long-term utility and reproducibility of results .

How can researchers troubleshoot non-specific binding issues with the SPAC27D7.11c antibody?

Non-specific binding is a common challenge with polyclonal antibodies. To address this issue with the SPAC27D7.11c antibody:

• Increase blocking stringency using 5% BSA or commercial blocking reagents

• Extend blocking time to 2 hours at room temperature or overnight at 4°C

• Add 0.1-0.3% Tween-20 to wash buffers to reduce hydrophobic interactions

• Perform pre-adsorption against yeast lysates lacking the target protein

• Include competing antigens to confirm epitope specificity

This approach parallels competition binding assays used to characterize antibody specificity in other research fields . When analyzing results, researchers should quantify both on-target and off-target signals to determine a specificity index.

What positive and negative controls should be included when using this antibody?

For rigorous experimental design with the SPAC27D7.11c antibody, the following controls are essential:

This control framework derives from established principles in immunodetection methodologies and parallels approaches used in characterizing novel monoclonal antibodies against other targets .

How can the SPAC27D7.11c antibody be used to study protein-protein interactions in yeast?

For investigating protein-protein interactions involving SPAC27D7.11c:

• Co-immunoprecipitation (Co-IP): Though not explicitly validated for IP, researchers can attempt immunoprecipitation with this antibody following crosslinking protocols. Use a moderate stringency lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% NP-40) supplemented with protease inhibitors.

• Proximity-based labeling: Adapt BioID or APEX2 systems by fusing these enzymes to SPAC27D7.11c, then use the antibody to confirm expression and proper localization of the fusion protein.

• Validation: Confirm interactions using reciprocal pulldowns and mass spectrometry identification, with interaction scoring similar to approaches used in antibody discovery platforms .

This methodology leverages principles established in antibody-based interaction screening while adapting them to yeast-specific research contexts.

What considerations are important when using the SPAC27D7.11c antibody for comparative studies across different yeast strains?

When conducting comparative studies across yeast strains:

• Sequence alignment: First perform bioinformatic analysis of SPAC27D7.11c homologs in target strains to predict epitope conservation. This is critical as the antibody was raised against a specific strain (972/ATCC 24843) .

• Cross-reactivity testing: Before full experiments, test cross-reactivity against lysates from each strain, quantifying relative signal intensities.

• Normalization strategy: Develop appropriate normalization controls for each strain, accounting for potential differences in extraction efficiency.

• Epitope accessibility: Consider native protein conformation differences between strains that might affect epitope accessibility, particularly in non-denaturing applications.

This systematic approach mirrors methodologies used in establishing specificity profiles for antibodies targeting conserved epitopes across species variants .

How can the SPAC27D7.11c antibody be validated for detecting post-translational modifications?

For studying post-translational modifications (PTMs) of SPAC27D7.11c:

• Establish PTM baseline: Use immunoprecipitation followed by mass spectrometry to identify endogenous PTMs on SPAC27D7.11c.

• Epitope mapping: Determine if the polyclonal antibody's epitopes overlap with potential modification sites using peptide arrays.

• Modification-specific detection:

  • For phosphorylation: Compare antibody binding before and after phosphatase treatment

  • For glycosylation: Compare binding before and after glycosidase treatment

  • For ubiquitination: Compare binding patterns under proteasome inhibition

• Quantitative analysis: Develop a ratio-based approach comparing modified to unmodified forms, similar to methods used in glycosylation-specific antibody development .

This approach integrates methodologies from glycoprotein antibody research while adapting them to yeast-specific PTM analysis.

How should researchers design time-course experiments to study SPAC27D7.11c expression dynamics?

For robust time-course analysis of SPAC27D7.11c expression:

• Experimental design:

  • Synchronize yeast cultures using established methods (nitrogen starvation or elutriation)

  • Collect samples at minimum 6-8 timepoints spanning the cell cycle or response period

  • Process samples consistently using identical lysis and protein extraction protocols

• Quantification approach:

  • Use digital imaging systems with linear detection range

  • Normalize SPAC27D7.11c signal to multiple housekeeping controls

  • Apply time-series statistical methods to identify significant changes

• Validation: Confirm protein-level changes with corresponding mRNA analysis via RT-qPCR

This methodology applies principles similar to those used in longitudinal antibody epitope profiling studies to yeast protein expression analysis.

What statistical approaches are recommended for analyzing variability in SPAC27D7.11c antibody-based assays?

When analyzing data from SPAC27D7.11c antibody experiments:

• Technical variability assessment:

  • Run at least 3-4 technical replicates per biological sample

  • Calculate intra-assay coefficient of variation (CV); target <15% for Western blots

  • For ELISA applications, generate standard curves with recombinant protein (supplied as positive control)

• Statistical analysis framework:

  • For comparative studies: Apply ANOVA with appropriate post-hoc tests

  • For correlation studies: Use regression analysis with confidence intervals

  • For binding kinetics: Apply non-linear regression models

• Visualization: Present data with individual data points alongside means and error bars (preferably 95% confidence intervals)

This statistical approach parallels methodologies used in antibody competition binding assays that require precise quantitative analysis .

How can the SPAC27D7.11c antibody be integrated into multiplexed detection systems?

For multiplexed analysis incorporating SPAC27D7.11c detection:

• Fluorescence multiplexing:

  • Conjugate the antibody with fluorophores (e.g., Alexa dyes) following established conjugation protocols

  • Validate that conjugation doesn't affect epitope binding using parallel unconjugated antibody controls

  • Select fluorophores with minimal spectral overlap for multi-target imaging

• Sequential immunoblotting:

  • Establish a stripping protocol that preserves membrane integrity while removing previous antibodies

  • Verify complete stripping using secondary-only controls

  • Document signal reduction factors through multiple stripping cycles

• Bead-based multiplex assays:

  • Conjugate the antibody to distinguishable beads following manufacturer protocols

  • Establish cross-reactivity profiles against other targets in the multiplex panel

  • Develop a standard curve using the purified antigen

This multiplexed approach adapts methodologies from high-throughput antibody screening platforms to specific SPAC27D7.11c research applications.

How can researchers adapt the SPAC27D7.11c antibody for super-resolution microscopy applications?

For super-resolution microscopy with SPAC27D7.11c antibody:

• Antibody modification:

  • Direct labeling with photo-switchable fluorophores (e.g., Alexa 647)

  • Validation of labeled antibody using standard immunofluorescence before proceeding to super-resolution

  • Titration to identify optimal concentration that balances specific signal and background

• Sample preparation considerations:

  • Use fixation protocols optimized for epitope preservation (start with 4% PFA)

  • Implement additional permeabilization steps optimized for yeast cell wall

  • Consider embedding in specialized media for STORM/PALM techniques

• Controls and validation:

  • Include peptide competition controls to confirm signal specificity

  • Perform correlative imaging with standard confocal microscopy

  • Quantify localization precision and compare to theoretical limits

This approach adapts principles from antibody-based super-resolution imaging while addressing the specific challenges of yeast cell imaging.

What considerations are important when using the SPAC27D7.11c antibody in chromatin immunoprecipitation experiments?

For adapting the SPAC27D7.11c antibody to ChIP applications:

• Pre-experimental validation:

  • Confirm nuclear localization of SPAC27D7.11c using cellular fractionation

  • Test antibody in standard IP format to verify pull-down efficiency

  • Determine optimal crosslinking conditions (formaldehyde concentration and time)

• Protocol optimization:

  • Develop specialized cell lysis procedures addressing yeast cell wall

  • Optimize sonication parameters to achieve 200-500bp chromatin fragments

  • Implement stringent washing steps to minimize background

• Quality control metrics:

  • Calculate enrichment factors relative to IgG controls

  • Verify enrichment at expected genomic loci via qPCR before proceeding to sequencing

  • Establish reproducibility thresholds across biological replicates

This methodology integrates approaches from antibody epitope mapping studies with chromatin biology techniques.

How can computational modeling enhance epitope prediction for the SPAC27D7.11c antibody?

For computational analysis of SPAC27D7.11c antibody epitopes:

• Structural modeling:

  • Generate 3D protein structure models using AlphaFold or similar tools

  • Map surface accessibility to identify probable epitope regions

  • Correlate models with sequence conservation analysis

• Epitope prediction workflow:

  • Apply B-cell epitope prediction algorithms to the SPAC27D7.11c sequence

  • Prioritize regions with high surface accessibility and hydrophilicity

  • Compare predictions with known immunogenic regions in related proteins

• Validation approach:

  • Synthesize predicted epitope peptides for ELISA-based binding validation

  • Develop blocking experiments using synthetic peptides

  • Correlate computational predictions with experimental findings

This computational approach parallels methodologies used in advanced antibody development pipelines where epitope-specific antibodies are crucial for distinguishing protein variants .